Testing effectiveness (Phase 2)UnknownNCT00423397
What this trial is testing
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
Who this might be right for
Non-melanomatous Skin Cancer
University of California, San Diego 16